↓ Skip to main content

Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment

Overview of attention for article published in BMC Pulmonary Medicine, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment
Published in
BMC Pulmonary Medicine, May 2021
DOI 10.1186/s12890-021-01539-x
Pubmed ID
Authors

Yang Yang, Qilong Liu, Lei Cao, Wei Sun, Xiaowei Gu, Bin Liu, Na Xiao, Fei Teng, Xiaoli Li, Meiji Chen, Weiguang Yu, Huanyi Lin, Guixing Xu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 23%
Student > Postgraduate 1 8%
Student > Doctoral Student 1 8%
Unknown 8 62%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 15%
Nursing and Health Professions 2 15%
Neuroscience 1 8%
Medicine and Dentistry 1 8%
Unknown 7 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2021.
All research outputs
#15,685,238
of 23,308,124 outputs
Outputs from BMC Pulmonary Medicine
#1,126
of 1,972 outputs
Outputs of similar age
#260,824
of 445,351 outputs
Outputs of similar age from BMC Pulmonary Medicine
#25
of 55 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,972 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,351 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.